
A Deep Dive Into Alzheimer's and Disturbing New Scientific Findings, with Dr. Dale Bredesen, Dr. Matthew Schrag, and Charles Piller | Ep. 373
The Megyn Kelly Show
00:00
Critical Scrutiny of Alzheimer's Research
This chapter uncovers alarming irregularities in the clinical trial data of a drug pivotal to Alzheimer's research, revealing potential manipulation by a neuroscientist. It emphasizes the need for rigorous examination of scientific integrity, particularly regarding imagery used in impactful studies, as well as the implications of these findings on patient safety and funding for alternative research theories. The discussion further challenges the dominant amyloid hypothesis, showcasing a pivotal study from 2006 that linked beta-amyloid oligomers to memory impairment, raising serious concerns about the validity and integrity of established scientific knowledge.
Transcript
Play full episode